HighTower Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-7,533
| Closed | -$265K | – | 3958 |
|
|
2025
Q4 | $265K | Buy |
+7,533
| New | +$267K | ﹤0.01% | 3150 |
|
|
2025
Q3 | – | Sell |
-9,554
| Closed | -$253K | – | 4080 |
|
|
2025
Q2 | $253K | Buy |
9,554
+73
| +0.8% | +$1.92K | ﹤0.01% | 3079 |
|
|
2025
Q1 | $229K | Buy |
9,481
+4,020
| +74% | +$127K | ﹤0.01% | 3075 |
|
|
2024
Q4 | $220K | Sell |
5,461
-2,521
| -32% | -$144K | ﹤0.01% | 3126 |
|
|
2024
Q3 | $507K | Buy |
7,982
+3,247
| +69% | +$190K | ﹤0.01% | 2391 |
|
|
2024
Q2 | $251K | Sell |
4,735
-383
| -7% | -$25.1K | ﹤0.01% | 2868 |
|
|
2024
Q1 | $419K | Buy |
+5,118
| New | +$228K | ﹤0.01% | 2404 |
|
|
2021
Q4 | – | Sell |
-11,561
| Closed | -$72K | – | 3492 |
|
|
2021
Q3 | $72K | Sell |
11,561
-120
| -1% | -$741 | ﹤0.01% | 2895 |
|
|
2021
Q2 | $71K | Buy |
11,681
+882
| +8% | +$5.24K | ﹤0.01% | 2856 |
|
|
2021
Q1 | $68K | Buy |
+10,799
| New | +$76K | ﹤0.01% | 2798 |
|
|
2020
Q4 | – | Sell |
-10,601
| Closed | -$62K | – | 2850 |
|
|
2020
Q3 | $62K | Sell |
10,601
-929
| -8% | -$6.4K | ﹤0.01% | 2289 |
|
|
2020
Q2 | $83K | Buy |
11,530
+1,804
| +19% | +$12K | ﹤0.01% | 2150 |
|
|
2020
Q1 | $44K | Buy |
+9,726
| New | +$59.8K | ﹤0.01% | 2021 |
|
|
2019
Q2 | – | Sell |
-21,848
| Closed | -$217K | – | 2521 |
|
|
2019
Q1 | $217K | Hold |
21,848
| – | – | ﹤0.01% | 1908 |
|
|
2018
Q4 | $167K | Buy |
21,848
+2,012
| +10% | +$24.1K | ﹤0.01% | 1884 |
|
|
2018
Q3 | $344K | Buy |
+19,836
| New | +$236K | ﹤0.01% | 1658 |
|
Other funds holding VKTX
VCM
VPM
